OUTPATIENT SUBCUTANEOUS ALEMTUZUMAB IS FEASIBLE AND SAFE FOR APLASTIC ANEMIA AND ASSOCIATED WITH HIGH RESPONSE RATES
- Resource Type
- Abstract
- Source
- In
Hematology, Transfusion and Cell Therapy October 2023 45 Supplement 4:S17-S17 - Subject
- Language
- ISSN
- 2531-1379